China National Accord Medicines Corporation Ltd.’s Net Profit Rose 29.5% in First Half of 2023

China National Accord Medicines Corporation Ltd. (国药集团一致药业股份有限公司) (000028.SZ) reported a net profit of 1 billion yuan in the first half of 2023, up 29.5% year-on-year.

Meanwhile, the company posted 38.4 billion yuan in revenue, up 6.3% year-on-year.

At the end of the reporting period, it had 49.9 billion yuan in total assets and 29.8 billion yuan in total liabilities, with a liability-to-asset ratio of 59.7%.